Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Supernus Pharmaceuticals Inc patents

Recent patent applications related to Supernus Pharmaceuticals Inc. Supernus Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Supernus Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Supernus Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Supernus Pharmaceuticals Inc-related inventors




Date Supernus Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
09/21/17Sustained-release formulations of topiramate
09/21/17Method of treatment of attention deficit/hyperactivity disorder (adhd)
09/14/17Formulations of viloxazine
04/13/17Methods of producing molindone and its salts
03/02/17Modified release preparations containing oxcarbazepine and derivatives thereof
12/29/16Sustained-release formulations of topiramate
12/29/16Sustained-release formulations of topiramate
10/20/16Methods for producing viloxazine salts and novel polymorphs thereof
09/29/16Formulations of viloxazine
09/15/16Osmotic drug delivery system
09/08/16Formulations of viloxazine
05/19/16Method of treatment of cns disorders
02/04/16Osmotic drug delivery system
01/28/16Sustained-release formulations of topiramate
01/14/16Formulations of mazindol
12/17/15Modified release preparations containing oxcarbazepine and derivatives thereof
12/17/15Modified release preparations containing oxcarbazepine and derivatives thereof
10/15/15Method of treatment of attention deficit/hyperactivity disorder (adhd)
06/04/15Drug formulations having reduced abuse potential
05/21/15Methods of producing molindone and its salts
05/07/15Methods for producing viloxazine salts and novel polymorphs thereof
04/09/15Modified release preparations containing oxcarbazepine and derivatives thereof
04/02/15Modified release preparations containing oxcarbazepine and derivatives thereof
03/26/15Stabilized formulations of cns compounds
02/26/15Once daily formulations of tetracyclines
01/22/15Enhanced immediate release formulations of topiramate
01/15/15Sustained-release formulations of topiramate
10/09/14Osmotic drug delivery system
07/03/14Method of treatment of aggression
05/15/14Method of treatment of aggression
04/10/14Modified release preparations containing oxcarbazepine and derivatives thereof
02/06/14Controlled release compositions of gamma-hydroxybutyrate
08/08/13Formulations of viloxazine
04/11/13Once daily trospium chloride treatment method
01/10/13Formulations of mazindol
12/20/12Sustained-release formulations of topiramate
09/13/12Controlled release compositions of gamma-hydroxybutyrate
09/13/12Modified release preparations containing oxcarbazepine and derivatives thereof
12/29/11Once daily formulations of tetracyclines
12/08/11Modified release preparations containing oxcarbazepine and derivatives thereof
12/01/11Once daily formulations of tetracyclines
11/24/11Sustained-release formulations of topiramate
11/24/11Sustained-release formulations of topiramate
11/24/11Once daily formulations of tetracyclines
10/13/11Methods for producing viloxazine salts and novel polymorphs thereof
10/06/11Stabilized formulations of cns compounds
09/01/11Use of a mixture of two or more enteric materials to regulate drug release via membrance or matrix for systemic therapeutics
01/06/11Method of treatment of a neurological disorder
09/02/10Pharmaceutical composition for the once-a-day oral administration of trospium chloride
09/02/10Pharmaceutical composition for once-a-day administration of trospium chloride
09/02/10Pharmaceutical composition for once-a-day oral administration of trospium chloride
09/02/10Pharmaceutical composition for once-a-day oral administration of trospium chloride
09/02/10Pharmaceutical composition for once a day administration of trospium chloride
09/02/10Pharmaceutical composition comprising trospium chloride for once-a-day administration
08/19/10Formulations of desvenlafaxine
07/08/10Method of treatment of aggression
03/18/10Method of treatment of attention deficit/hyperactivity disorder (adhd)
12/10/09Controlled release formulations of pramipexole
11/12/09Controlled release formulations of alprazolam







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Supernus Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Supernus Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';